A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA receives more than 100 adverse event reports related to children and adults who consumed edible products containing THC, including hospitalizations
Published: May 13, 2022 by Food Safety News
FDA approves Alembic Pharmaceuticals’ ANDA for arformoterol tartrate inhalation solution, 15 mcg/2 mL unit-dose to treat chronic obstructive pulmonary bronchoconstriction; drug is therapeutic equivalent of Sunovion Pharmaceuticals’ Brovana
Published: May 13, 2022 by PharmaBiz
FDA gives breakthrough therapy designation to Zambon’s inhaled colistimethate sodium powder to treat pulmonary exacerbations in non-cystic fibrosis bronchiectasis; treatment uses adaptive aerosol delivery battery-powered I-neb nebulizer
Published: May 13, 2022 by PharmaBiz
FDA approves Hologic’s Aptima CMV Quant assay for use with Hologic’s automated Panther system for solid organ, stem cell transplant patients; test is firm's first post-transplant pathogen detection test in US, joins tests for HIV-1, hepatitis C and B
Published: May 12, 2022 by Business Wire
FDA approves Eli Lilly’s oral Olumiant as a standalone COVID-19 treatment for hospitalized adult patients using supplemental oxygen or ventilation; Olumiant has treated over one million patients with sales up from US$437.0M in 2019 to US$1.1B in 2021
Published: May 12, 2022 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count